Skip to content

Effects of Korodin? Herz-Kreislauf-Tropfen on low blood pressure and cognitive functions in adolescents

Effects of Korodin? Herz-Kreislauf-Tropfen on low blood pressure and cognitive functions in adolescents

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2014-005327-27-DE
Enrollment
100
Registered
2015-05-22
Start date
Unknown
Completion date
Unknown
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

low blood pressure

Interventions

Sponsors

Robugen GmbH
Lead Sponsor
Robugen GmbH
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: low blood pressure Subjects must have low blood pressure but be otherwise healthy as judged on the Basis of a medical examination Are the trial subjects under 18? yes Number of subjects for this age range: 100 F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: no low blood pressure other medications, alcohol if female: pregnancy

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s): Change of low blood pressure;Timepoint(s) of evaluation of this end point: Change of low blood pressure before - meanwhile and after Trial - 1,3,7,15 minutes after oral intake

Secondary

MeasureTime frame
Secondary end point(s): Change of cognitive and mental functions;Timepoint(s) of evaluation of this end point: immediately after trial 15 and 30 minutes

Countries

Germany

Contacts

Public ContactRobugen GmbH

Robugen GmbH

mauzm@robugen.de004971113630111

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026